Table 4.
Variable | OS | PFS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | Cox P‐value | HR | 95% CI | Cox P‐value | |
Cytopenias: 2‐3 | 1.66 | [1.04‐2.63] | 0.032 | 1.64 | [1.03‐2.60] | 0.036 |
Transfusion dependence | 1.78 | [1.12‐2.82] | 0.014 | 1.68 | [1.06‐2.65] | 0.027 |
AML with 21%‐30% blasts in the bone marrow | 2.01 | [1.22‐3.31] | 0.006 | 1.83 | [1.11‐3.00] | 0.017 |
Poor karyotype (IPSS score) | 2.73 | [1.49‐4.99] | 0.001 | 2.92 | [1.62‐5.26] | <0.001 |
Poor and very poor karyotype (IPSS‐R score) | 2.86 | [1.60‐5.09] | <0.001 | 2.87 | [1.66‐4.94] | <0.001 |
High IPSS score | 2.62 | [1.83‐3.76] | <0.001 | 2.47 | [1.71‐3.58] | <0.001 |
<80% RDI (time‐dependent) | 0.732 | [0.44‐1.16] | 0.182 | 1.02 | [0.69‐1.51] | 0.911 |
AML, acute myeloid leukemia; OS, Overall survivals; PFS, progression‐free survivals; RDI, relative dose intensity.